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A 69-year-old man underwent endoscopic submucosal dissection (ESD) for early gastric cancer (EGC) 
at the lesser curvature in the angle of stomach.  Histological examination revealed tub1,  pM,  ly0,  v0,  
pLM(-),  pVM(-),  and the resection was considered curative.  The scar after ESD was followed by 
esophagogastroduodenoscopy (EGD) and biopsy.  Twenty months later,  EGD showed an ulcerative 
lesion in the vicinity of the ESD scar,  and histological examination of the biopsy specimen showed 
adenocarcinoma.  A distal gastrectomy with lymph node dissection was then performed.  Postoperative 
pathology showed tub1,  pM,  pN0,  ly0,  v0,  and Stage 1A.  Skip lesions were seen in the specimen 
resected by ESD,  and the histological review conﬁrmed so-called “dysplasia-like atypia” (DLA) between 
the lesions.  It has been reported recently that in DLA,  the dysplasia-like change involves only the bases 
of the pits,  without upper pit or surface epithelium involvement,  and it is said that the rate of DLA is 
higher in gastric cancer patients.  We speculated that a precancerous lesion close to the resected cancer 
developed into a local recurrence.
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E ndoscopic submucosal dissection (ESD) is widely accepted in the treatment of early gastric can-
cers (EGCs) when lymph node metastasis is negligible 
[1-3].  Since ESD is less invasive and able to pre-
serve the entire stomach,  patientsʼ postoperative 
quality of life is maintained.  In the case of curative 
resection judged by the Japanese Gastric Cancer 
Treatment Guidelines [4],  local or metastatic recur-
rence are extremely rare.  The incidence rate of local 
recurrence has been reported to be 0-0.4  [5-7].
　 We report a case of local recurrence after curative 
ESD of mucosal EGC.  In this case,  histological 
examination showed dysplasia-like atypia (DLA) close 
to the cancer in the specimen resected by ESD.  It has 
been reported that the dysplasia-like change in DLA 
involves only the bases of the pits,  not the upper pit 
or surface epithelium.  Some studies have reported 
that in DLA,  the neoplastic precursor lesion is 
located close to the cancer [13-15].  This suggests 
Acta Med.  Okayama,  2016
Vol.  70,  No.  3,  pp.  213-216
CopyrightⒸ 2016 by Okayama University Medical School.
Case Report http ://escholarship.lib.okayama-u.ac.jp/amo/
Received September 4, 2015 ; accepted December 16, 2015.
＊Corresponding author. Phone : ＋81-86-235-7257; Fax : ＋81-86-221-8775
E-mail : satorukc@hotmail.com (S. Kikuchi)
Conﬂict of Interest Disclosures: No potential conﬂict of interest relevant 
to this article was reported.
that local recurrence may arise from DLA after cura-
tive resection of ESD.
Case Report
　 A 69-year-old man as part of his annual screening 
underwent an upper gastrointestinal series that detected 
an abnormality in the stomach.  EGD revealed a slightly 
elevated lesion,  50mm in diameter,  at the lesser 
curvature in the angle of stomach,  and biopsy indi-
cated a well-diﬀerentiated adenocarcinoma (Fig.  1A).  
There were no speciﬁc ﬁndings on physical examina-
tion or laboratory data,  including tumor markers.  
Endoscopic ultrasound showed the lesion to be con-
ﬁned to the mucosa.  On preoperative computed 
tomography (CT),  there were no swollen lymph nodes 
or distant metastases.  ESD was performed on this 
lesion,  resulting in an en bloc resection (Fig.  1B).  
Pathological examination revealed 2 well-diﬀerenti-
ated adenocarcinomas,  17mm and 6mm in size,  
respectively (Fig.  1C,  red lines).  Both cancer lesions 
were surrounded with dysplasia-like lesions (Fig.  1C,  
yellow lines),  and these cancer lesions were conﬁned 
to the mucosa,  without lymphovascular involvement.  
The lateral and vertical margins were negative for 
both cancer and dysplasia-like lesion invasions,  so it 
was judged that the resection was curative based on 
standard criteria.  The tumors were,  however,  sur-
rounded by atypical glands as seen in dysplasia.  
Follow-up EGD examinations were performed every 
3-6 months.  A small ulcer was detected at the center 
of the ESD scar and a slightly elevated lesion was 
found near the ESD scar,  but there was no evidence 
of malignancy on histological examination of the biopsy 
specimen.  Twenty-one months after ESD,  EGD 
revealed a small ulcerative lesion in the center of the 
ESD scar,  and biopsies of the slightly elevated lesions 
around the ulcerative lesion indicated well-diﬀerenti-
ated adenocarcinoma (Fig.  2).  Repeated ESD for this 
relapse lesion was considered technically diﬃcult 
because of severe ﬁbrosis in the submucosal layer at 
the site of the initial ESD.  Distal gastrectomy with 
lymph node dissection was performed,  and histological 
examination of the resected stomach revealed adjacent 
to the initial ESD scar a well-diﬀerentiated adenocar-
cinoma,  50×42mm in size,  that was restricted to the 
mucosa without lymphovascular involvement or lymph 
node metastasis.
　 The primary sections that were dissected by ESD 
were reviewed retrospectively.  There were cytologic 
and architectural atypia of the glands at the bases,  
conﬁrming that DLA was present close to the cancer 
lesions at the time of initial resection (Figs.  1C,  3A,  
3B).  Immunohistochemical staining for Ki-67 was also 
performed,  and Ki-67-positive cells were present at 
higher levels where there were architectural atypia of 
the glands (Fig.  3C) than where conventional intestinal 
metaplasia (IM) existed.  During the 3-year follow-up 
period in this patient,  there was no evidence of recur-
rence.
Discussion
　 ESD is widely accepted for the treatment of EGC 
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Fig. 1　 (A) Esophagogastroduodenoscopy shows a slightly elevated lesion (0-IIa),  50mm in diameter,  at the lesser curvature in the 
angle of stomach.  (B) En bloc resection of the specimen.  (C) Tumor mapping shows two cancer lesions (red lines) among dysplasia-like 
lesions (yellow lines).  Retrospectively,  the DLA was conﬁrmed close to the cancer lesions (blue line).
when lymph node metastasis is negligible [1-3].  ESD 
is less invasive and able to preserve the entire stom-
ach,  allowing patients to maintain their quality of life 
postoperatively.  When the lesion is completely resected 
and judged to be a curative resection according to the 
Japanese Gastric Cancer Treatment Guidelines [4],  
the local recurrence rate has been reported to be 
0-0.4  [5-7].  In cases of local recurrence,  although 
rare,  it has been unclear whether these lesions coinci-
dentally developed near the ESD scar or were resid-
ual.  It is known that EGC is often accompanied by 
synchronous or metachronous multiple gastric cancers 
[1,  8,  9].  Kato et al.  [7] reported that about 14  of 
the patients who underwent ESD had multiple gastric 
cancers,  and about 19  of concomitant lesions were 
missed by preoperative endoscopic evaluation.  The 
miss rate was associated with the experience of the 
endoscopist and the location of the missed cancers.  In 
the current case,  the local recurrence arose in the 
angle of stomach,  which is relatively easy to observe,  
and multiple preoperative endoscopic evaluations were 
performed by experienced endoscopists.  A concomi-
tant lesion was unlikely to have been missed in this 
endoscopic survey.
　 Most intestinal-type gastric cancers are considered 
to develop through an intestinal metaplasia (IM)-
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Fig.2　(A),  (B) Esophagogastroduodenoscopy shows a small 
ulcerative lesion in the center of the ESD scar 21 months after ESD.  




Fig. 3　 (A),  (B) Histological examination shows that the features 
of DLA－nuclear elongation,  hyperchromatism,  and pseudostratiﬁ-
cation－are present close to the cancer lesion.  They are limited to 
the bases of the gastric pits,  without surface involvement.  H & E 
stain.  (C) Immunohistochemical staining for Ki-67 in DLA.  Ki-67-
positive cells are present at higher levels in the pit.
dysplasia-carcinoma pathway [10,  11].  In this case,  
it was retrospectively found that the primary lesion 
that was dissected by ESD was surrounded by mucosa 
with DLA.  The term “Gastric DLA” was described by 
Brien in 2001; its pathological features are atypical 
changes present in the foveolar and glandular epithe-
lium in a discontinuous or patchy fashion,  surface 
maturation,  an open nuclear chromatin pattern with 
prominent nucleoli,  retention of nuclear polarity,  and 
mitoses conﬁned to the pits [12].  They deﬁned gastric 
DLA as a non-neoplastic lesion.  However,  Agoston et al.  
[13] and others [14,  15] recently reported that the 
rate of DLA was higher in gastric cancer patients than 
in control patients without gastric cancers,  and DLA 
showed a higher Ki-67-positive rate than intestinal 
metaplasia.  Furthermore,  Ki-67-positive cells were 
present at higher levels in the pit with DLA than with 
intestinal metaplasia.  They concluded that DLA rep-
resents an important precursor lesion in gastric carci-
nogenesis.  In the present case,  cytologic and architec-
tural atypia of the glands at the bases were 
histologically conﬁrmed close to the cancer lesions,  
and Ki-67-positive cells were present at higher levels 
where architectural atypia of the glands existed,  cor-
responding to DLA.  Conventional dysplasia was also 
conﬁrmed in the initial resected specimen.  This sug-
gests that both the remnant DLA and dysplastic 
lesions close to the resected initial gastric cancer 
contributed to the carcinogenesis.
Conclusion
　 Although local recurrence after curative ESD for 
early gastric cancer is extremely rare,  remnant DLA 
lesions close to the cancer lesion can cause recur-
rence.  Physicians must keep DLA in mind as a pre-
cursor neoplastic lesion in gastric carcinogenesis.  
Needless to say,  careful follow-up is mandatory,  even 
after curative ESD.
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